Neurosense Therapeutics Stock Forecast

Hold candidate since Jul 28, 2026

The Neurosense Therapeutics Ltd. stock price gained 0.604% on the last trading day (Friday, 31st Jul 2026), rising from $0.0994 to $0.100. During the last trading day the stock fluctuated 0% from a day low at $0.100 to a day high of $0.100. The price has fallen in 4 of the last 10 days. Volume fell on the last day by -517 shares and in total, 5 shares were bought and sold for approximately $0.500 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.111 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -41.84% during the next 3 months and, with a 90% probability hold a price between $0.0212 and $0.0643 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NRSNW Signals & Forecast

The Neurosense Therapeutics Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.0827 and $0.0920. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 14, 2026, and so far it has fallen -21.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Neurosense Therapeutics Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0907 and $0.0805. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Neurosense Therapeutics Ltd. finds support just below today's level at $0.0907. If this is broken, then the next support from accumulated volume will be at $0.0805 and $0.0800.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 106.45%.

Our recommended stop-loss: $0.0942 (-5.76%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (NRSNW) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Neurosense Therapeutics Ltd. to open at $0.100, and during the day (based on 14 day Average True Range), to move between $0.0602 and $0.140, which gives a possible trading interval of +/-$0.0796 (+/-132.16%) up or down from last closing price. If Neurosense Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 132.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.101 (0.50%) than the support at $0.0907 (9.30%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neurosense Therapeutics Ltd. stock A Buy?

Neurosense Therapeutics Ltd. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.765 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.100 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk